Injective Chief Backs US Crypto Clarity Act
Injective policy chief John Medel argues the Clarity Act is essential to lock in current US crypto rules against future administrative shifts.
John Medel, policy chief at Injective Labs, stated that the Clarity Act will provide long-term regulatory certainty for the US crypto sector. He emphasized that current rules rely heavily on executive action, which lacks durability.
Medel noted that regulators are already implementing broad policies without a permanent statutory framework. He warned that reliance on the current administration alone leaves the sector vulnerable to political changes.
Legislation Stabilizes Regulatory Direction
According to Medel, congressional legislation strengthens the institutional foundation of the market. The Clarity Act serves as a mechanism to anchor the current regulatory path in law. This approach reduces the risk of abrupt policy reversals.
He described the bill as a chance to give permanence to existing directives. This legal stability is critical for market participants planning long-term operations. The argument aligns with broader industry calls for clear market structure rules.
Industry Relies On Statutory Framework
Medel pointed out that agency-level policies can shift with leadership changes. Congressional approval creates a harder barrier for future modifications. This distinction is central to the debate over crypto market structure in the US.
The Clarity Act aims to define the roles of regulators and exchanges clearly. This clarity supports investor protection and market confidence. Industry leaders view this legislative step as a necessary correction to the current ad-hoc regulatory environment.
Long Term Certainty For Markets
As reported by GN markets/crypto, the push for this bill reflects growing demand for regulatory predictability. Medel’s comments highlight the strategic importance of moving beyond temporary executive orders. The goal is to establish a durable legal baseline for digital assets.
This perspective underscores the tension between agile agency rulemaking and stable legislative frameworks. For Injective and other participants, the Clarity Act represents a key opportunity. Securing this legislation would solidify the current regulatory stance for the foreseeable future.
